141 related articles for article (PubMed ID: 16181123)
1. Stromal derived growth factor-1alpha as a beacon for stem cell homing in development and injury.
Claps CM; Corcoran KE; Cho KJ; Rameshwar P
Curr Neurovasc Res; 2005 Oct; 2(4):319-29. PubMed ID: 16181123
[TBL] [Abstract][Full Text] [Related]
2. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats.
Hatch HM; Zheng D; Jorgensen ML; Petersen BE
Cloning Stem Cells; 2002; 4(4):339-51. PubMed ID: 12626097
[TBL] [Abstract][Full Text] [Related]
3. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
[TBL] [Abstract][Full Text] [Related]
4. Binding of stromal derived factor-1alpha (SDF-1alpha) to CXCR4 chemokine receptor in normal human megakaryoblasts but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT.
Majka M; Ratajczak J; Kowalska MA; Ratajczak MZ
Eur J Haematol; 2000 Mar; 64(3):164-72. PubMed ID: 10997882
[TBL] [Abstract][Full Text] [Related]
5. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
[TBL] [Abstract][Full Text] [Related]
6. Circulating CXCR4-positive stem/progenitor cells compete for SDF-1-positive niches in bone marrow, muscle and neural tissues: an alternative hypothesis to stem cell plasticity.
Pituch-Noworolska A; Majka M; Janowska-Wieczorek A; Baj-Krzyworzeka M; Urbanowicz B; Malec E; Ratajczak MZ
Folia Histochem Cytobiol; 2003; 41(1):13-21. PubMed ID: 12705474
[TBL] [Abstract][Full Text] [Related]
7. Stromal-derived factor-1alpha/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space.
Oonakahara K; Matsuyama W; Higashimoto I; Kawabata M; Arimura K; Osame M
Am J Respir Cell Mol Biol; 2004 May; 30(5):671-7. PubMed ID: 14672915
[TBL] [Abstract][Full Text] [Related]
8. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
[TBL] [Abstract][Full Text] [Related]
9. Stromal-derived factor-1/CXCR4 signaling: indispensable role in homing and engraftment of hematopoietic stem cells in bone marrow.
Sharma M; Afrin F; Satija N; Tripathi RP; Gangenahalli GU
Stem Cells Dev; 2011 Jun; 20(6):933-46. PubMed ID: 21186999
[TBL] [Abstract][Full Text] [Related]
10. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles.
Ratajczak MZ; Majka M; Kucia M; Drukala J; Pietrzkowski Z; Peiper S; Janowska-Wieczorek A
Stem Cells; 2003; 21(3):363-71. PubMed ID: 12743331
[TBL] [Abstract][Full Text] [Related]
11. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
12. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas.
Kayali AG; Van Gunst K; Campbell IL; Stotland A; Kritzik M; Liu G; Flodström-Tullberg M; Zhang YQ; Sarvetnick N
J Cell Biol; 2003 Nov; 163(4):859-69. PubMed ID: 14638861
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
Gazitt Y; Akay C
Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
[TBL] [Abstract][Full Text] [Related]
14. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
[TBL] [Abstract][Full Text] [Related]
15. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells.
Peng SB; Peek V; Zhai Y; Paul DC; Lou Q; Xia X; Eessalu T; Kohn W; Tang S
Mol Cancer Res; 2005 Apr; 3(4):227-36. PubMed ID: 15831676
[TBL] [Abstract][Full Text] [Related]
16. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow.
Ratajczak MZ; Kucia M; Reca R; Majka M; Janowska-Wieczorek A; Ratajczak J
Leukemia; 2004 Jan; 18(1):29-40. PubMed ID: 14586476
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
[TBL] [Abstract][Full Text] [Related]
18. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
[TBL] [Abstract][Full Text] [Related]
19. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury.
Tögel F; Isaac J; Hu Z; Weiss K; Westenfelder C
Kidney Int; 2005 May; 67(5):1772-84. PubMed ID: 15840024
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.
Dewan MZ; Ahmed S; Iwasaki Y; Ohba K; Toi M; Yamamoto N
Biomed Pharmacother; 2006 Jul; 60(6):273-6. PubMed ID: 16828253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
